Home > Insider Trading > Filing (0001179110-18-003697)

Filing Details

Accession Number:: 0001179110-18-003697
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-06 19:25:27
Reporting Period:: 2018-02-23

Accepted Time:: 2018-03-06 19:25:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
792977	Amag Pharmaceuticals Inc.	AMAG	Pharmaceutical Preparations (2834)	042742593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1551776	Joseph Vittiglio	C/O Amag Pharmaceuticals, Inc. 1100 Winter Street Waltham MA 02451	Evp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-02-23	869	$19.65	32,635	No	4	F	Direct
Common Stock	Acquisiton	2018-03-02	12,000	$0.00	44,635	No	4	A	Direct
Common Stock	Acquisiton	2018-03-02	10,000	$0.00	54,635	No	4	A	Direct
Common Stock	Disposition	2018-03-02	1,011	$21.00	53,624	No	4	F	Direct
Common Stock	Disposition	2018-03-06	770	$20.80	52,854	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	A	Direct
No	4	A	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2018-03-02	20,000	$0.00	20,000	$21.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000		2028-03-02	No	4	A	Direct

Footnotes

Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,499 restricted stock units ("RSUs") on February 23, 2018.
Each RSU represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's Fourth Amended and Restated 2007 Equity Incentive Plan (as amended the "Plan") and will vest in three equal annual installments with the first installment vesting on March 2, 2019.
Not applicable.
These shares of Common Stock are issuable pursuant to a performance-based RSU grant under a long-term incentive program under the Plan and will be earned, if at all, based on achievement of certain relative total stockholder return targets over the three year performance period ending March 1, 2021 subject to continuation of a business relationship with the grantee through the conclusion of the performance period. The number above represents the target number of shares that may be delivered pursuant to the award ("Target Award"); however, the amount that vests could range from zero to 150% of the Target Award.
Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 3,000 RSUs on March 1, 2018. Due to the black-out policies implemented by the Issuer, the shares of the Issuer's Common Stock underlying such vested RSUs were not delivered to the reporting person until March 2, 2018, at which time an aggregate of 1,011 shares were withheld to satisfy the reporting person's applicable tax obligations.
The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2017.
Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter.